血清化影响慢性毒性中飞胺的消除:一个案例报告
Rafael Lima1, Sydney Schacht2, Alan Hyslop3
1Division of Medical Toxicology, Department of Emergency Medicine, Indiana University, Indianapolis, Indiana, USA, indiana.edu.
Case reports in critical care
|November 17, 2025
概括
血清化可能会恶化慢性flekainide毒性,因为它会影响药物的排泄,即使没有超治疗性摄入. 这一发现影响了广泛复杂的心律失常症的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 临床药理学 临床药理学
- 毒理学 毒理学 毒理学
背景情况:
- 超治疗性弗莱卡因化水平可能会导致危险的广泛复杂的心脏节律失常.
- 超性二碳酸是一种常见的治疗方法,但化可能会阻碍弗莱卡因的排出.
- 之前的研究表明,由于性质的急性毒性,flekainide清除受损.
研究的目的:
- 为了研究血清化对慢性flekainide毒性的影响.
- 探索在治疗过程中增加弗莱卡因化度的潜在机制.
主要方法:
- 一个69岁的患者的病例报告,患有慢性flekainide毒性.
- 在血清化之前和之后的弗莱卡因化血清度的分析.
- 对二碳酸和利多卡因治疗反应的评估.
主要成果:
- 患者经历了复发性的宽复杂性心力衰竭,不耐标准治疗.
- 血清弗莱卡因化度似乎在血清化后增加.
- 经过性溶解和利多卡因给药后,心律失常症得到缓解.
结论:
- 在慢性毒性中,血清化可能会通过组织再分配损害弗莱卡尼德的消除.
- 化策略需要仔细考虑在管理flekainide的毒性.
- 这一案例突出了二碳酸治疗在弗莱卡因中毒中的潜在并发症.
相关概念视频
Renal Failure: Dose Adjustments
416
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
416
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
208
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208
Enhanced Elimination of Poison
846
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
846
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
225
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
225
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171


